What to know about Trump VP pick J.D. Vance’s health care views and investments

WASHINGTON — Sen. J.D. Vance, who was tapped to be former President Trump’s running mate on Monday, has a history of investing in health care companies — and of pursuing health care policies that are sometimes at odds with his party’s base.

Vance, as a Yale-educated venture capitalist, has invested in biotech startups developing new therapies, companies that aim to aid in drug discovery, health data companies, and health tech platforms, according to his federal financial disclosures.

Vance rose to prominence after his book “Hillbilly Elegy” about his impoverished childhood in Appalachia was published in 2016. He’s found friends in wealthy places since. He co-founded a venture capital firm, called Narya Capital, with funding from billionaire Peter Thiel and support from venture capital titan Marc Andreessen and former Google CEO Eric Schmidt. The firm has portfolio companies focused on health care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In